PubRank

Frank H Miller

Author PubWeight™ 97.11‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology 2009 3.57
2 Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival. J Clin Oncol 2009 3.43
3 Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology 2010 2.35
4 Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma. JAMA 2010 1.84
5 Computerized tomographic colonography: performance evaluation in a retrospective multicenter setting. Gastroenterology 2003 1.73
6 Accidental ureteral ligation during an inguinal hernia repair of patient with crossed fused renal ectopia. Clin Imaging 2002 1.70
7 Peroral esophageal myotomy (POEM) and laparoscopic Heller myotomy produce a similar short-term anatomic and functional effect. Surgery 2013 1.70
8 Response to treatment series: part 2, tumor response assessment--using new and conventional criteria. AJR Am J Roentgenol 2011 1.64
9 Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol 2011 1.62
10 Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort. Radiology 2010 1.55
11 ACR Appropriateness Criteria® right lower quadrant pain--suspected appendicitis. J Am Coll Radiol 2011 1.51
12 Imaging of hepatocellular carcinoma after treatment with yttrium-90 microspheres. AJR Am J Roentgenol 2007 1.45
13 Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival. Radiology 2008 1.45
14 Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres. Hepatology 2009 1.44
15 Prospective evaluation of patients with early-/intermediate-stage hepatocellular carcinoma with disease progression following arterial locoregional therapy: candidacy for systemic treatment or clinical trials. J Vasc Interv Radiol 2013 1.41
16 Pancreatic mucinous cystic neoplasm size using CT volumetry, spherical and ellipsoid formulas: validation study. JOP 2014 1.38
17 Biliary sequelae following radioembolization with Yttrium-90 microspheres. J Vasc Interv Radiol 2008 1.33
18 American Pancreatic Association Practice Guidelines in Chronic Pancreatitis: evidence-based report on diagnostic guidelines. Pancreas 2014 1.30
19 Diffusion-weighted MR imaging of solid and cystic lesions of the pancreas. Radiographics 2011 1.29
20 Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlation. J Hepatol 2010 1.25
21 Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times. Gastroenterology 2011 1.25
22 A comparison of chemoembolization endpoints using angiographic versus transcatheter intraarterial perfusion/MR imaging monitoring. J Vasc Interv Radiol 2007 1.23
23 Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma--feasibility of initial clinical translation. Radiology 2008 1.19
24 Radiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolization. Cardiovasc Intervent Radiol 2009 1.18
25 Multishot diffusion-weighted PROPELLER magnetic resonance imaging of the abdomen. Invest Radiol 2006 1.15
26 Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis. J Magn Reson Imaging 2012 1.13
27 Radiologic assessment of response to therapy: comparison of RECIST Versions 1.1 and 1.0. Radiographics 2011 1.11
28 Assessment of liver tumor response to therapy: role of quantitative imaging. Radiographics 2013 1.10
29 Imaging benign and malignant disease of the gallbladder. Radiol Clin North Am 2002 1.09
30 Diffusion-weighted magnetic resonance imaging of pancreatic adenocarcinomas: association with histopathology and tumor grade. J Magn Reson Imaging 2011 1.08
31 The nonvisualized appendix: incidence of acute appendicitis when secondary inflammatory changes are absent. AJR Am J Roentgenol 2004 1.08
32 Diffusion-weighted MR imaging in pancreatic endocrine tumors correlated with histopathologic characteristics. J Magn Reson Imaging 2011 1.06
33 Radioembolization for hepatocellular carcinoma with portal vein thrombosis: impact of liver function on systemic treatment options at disease progression. J Hepatol 2012 1.06
34 Videocapsule endoscopy versus barium contrast studies for the diagnosis of Crohn's disease recurrence involving the small intestine. Am J Gastroenterol 2004 1.05
35 ACR Appropriateness Criteria pretreatment staging of colorectal cancer. J Am Coll Radiol 2012 1.05
36 Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging. J Vasc Interv Radiol 2008 1.03
37 Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes. Int J Radiat Oncol Biol Phys 2011 1.01
38 In vivo diffusion-weighted imaging of liver tumor necrosis in the VX2 rabbit model at 1.5 Tesla. Invest Radiol 2006 1.00
39 Imaging in intestinal ischemic disorders. Radiol Clin North Am 2008 0.99
40 Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association. Radiology 2014 0.98
41 Magnetic resonance elastography and biomarkers to assess fibrosis from recurrent hepatitis C in liver transplant recipients. Transplantation 2011 0.97
42 Imaging features of the less common pancreatic masses. Abdom Imaging 2013 0.97
43 Radiologic findings following Y90 radioembolization for primary liver malignancies. Abdom Imaging 2009 0.97
44 Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: a subgroup analysis. J Hepatol 2012 0.96
45 Diffusion-weighted MR imaging for determination of hepatocellular carcinoma response to yttrium-90 radioembolization. J Vasc Interv Radiol 2006 0.96
46 Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging analysis from a prospective randomized trial of Y90 ± sorafenib. Hepatology 2013 0.95
47 Quantitative 4D transcatheter intraarterial perfusion MRI for monitoring chemoembolization of hepatocellular carcinoma. J Magn Reson Imaging 2010 0.94
48 Adrenal imaging: a comprehensive review. Radiol Clin North Am 2012 0.93
49 Gadolinium-enhanced 3D MR angiography of renal artery stenosis: a pilot comparison of maximum intensity projection, multiplanar reformatting, and 3D volume-rendering postprocessing algorithms. Acad Radiol 2002 0.91
50 Extrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: analyzing patterns of progression in 285 patients. Hepatology 2012 0.91
51 Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic association. Gastroenterology 2014 0.90
52 Multimodality imaging to assess immediate response to irreversible electroporation in a rat liver tumor model. Radiology 2014 0.90
53 Identification of adhesions on CT in small-bowel obstruction. Emerg Radiol 2005 0.90
54 MRI of islet cell tumors of the pancreas. AJR Am J Roentgenol 2006 0.89
55 ACR Appropriateness Criteria on colorectal cancer screening. J Am Coll Radiol 2010 0.89
56 ACR Appropriateness Criteria on Crohn's disease. J Am Coll Radiol 2010 0.88
57 MR imaging of the pancreas: a practical approach. Radiol Clin North Am 2002 0.87
58 Imaging of cystic diseases of the pancreas. Radiol Clin North Am 2002 0.87
59 Multidetector-row computed tomography diagnosis of small bowel obstruction: can coronal reformations replace axial images? Emerg Radiol 2006 0.87
60 Agreement between competing imaging measures of response of hepatocellular carcinoma to yttrium-90 radioembolization. J Vasc Interv Radiol 2010 0.87
61 MR imaging perfusion mismatch: a technique to verify successful targeting of liver tumors during transcatheter arterial chemoembolization. J Vasc Interv Radiol 2008 0.87
62 Magnetic resonance elastography and acoustic radiation force impulse for staging hepatic fibrosis: a meta-analysis. Abdom Imaging 2015 0.87
63 Biliary dilatation and duodenal intussusception secondary to enteric duplication cyst: MDCT diagnosis. Emerg Radiol 2008 0.86
64 ACR appropriateness criteria jaundice. J Am Coll Radiol 2013 0.86
65 Left lower-quadrant pain: guidelines from the American College of Radiology appropriateness criteria. Am Fam Physician 2010 0.86
66 Cross-sectional imaging of perforated gallbladder. Abdom Imaging 2014 0.84
67 Incidence of visualization of the normal appendix on different MRI sequences. Emerg Radiol 2006 0.84
68 Imaging of choledochal cysts. Abdom Imaging 2015 0.83
69 Response assessment methodologies in hepatocellular carcinoma: complexities in the era of local and systemic treatments. J Hepatol 2013 0.82
70 MRI-guided biopsy to correlate tissue specimens with MR elastography stiffness readings in liver transplants. Acad Radiol 2012 0.82
71 MRI detection of uterine necrosis after uterine artery embolization for fibroids. AJR Am J Roentgenol 2004 0.82
72 Infectious and inflammatory diseases of the kidney. Radiol Clin North Am 2012 0.82
73 Comparison of the sensitivity of a pre-MRI questionnaire and point of care eGFR testing for detection of impaired renal function. Acad Radiol 2012 0.82
74 MR imaging of hepatocellular carcinoma. Magn Reson Imaging Clin N Am 2010 0.82
75 Magnetic resonance imaging in patients with pancreatitis: evaluation of signal intensity and enhancement changes. J Magn Reson Imaging 2002 0.81
76 Will CT ordering practices change if we educate residents about the potential effects of radiation exposure? Experience at a large academic medical center. Acad Radiol 2011 0.81
77 CT and MR imaging for evaluation of cystic renal lesions and diseases. Radiographics 2015 0.81
78 Fluoroscopic findings post-peroral esophageal myotomy. Abdom Imaging 2015 0.80
79 MRI of mycotic sinus of valsalva pseudoaneurysm secondary to Aspergillus pericarditis. AJR Am J Roentgenol 2005 0.80
80 Chyluria. J Urol 2012 0.79
81 CT attenuation of unilocular pancreatic cystic lesions to differentiate pseudocysts from mucin-containing cysts. JOP 2011 0.79
82 Uterine artery embolization: pre- and post-procedural evaluation using magnetic resonance imaging. Abdom Imaging 2013 0.79
83 Adrenal hemangioma-adenoma: an exceedingly rare adrenal collision tumor. J Magn Reson Imaging 2009 0.79
84 Incidence of nonviable leiomyomas on contrast material-enhanced pelvic MR imaging in patients referred for uterine artery embolization. J Vasc Interv Radiol 2005 0.79
85 Can volumetric ADC measurement help predict response to Y90 radioembolization in HCC? Abdom Imaging 2015 0.78
86 Imaging tumor response following liver-directed intra-arterial therapy. Abdom Imaging 2013 0.78
87 Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report. Pediatr Radiol 2013 0.77
88 Imaging features of benign and malignant ampullary and periampullary lesions. Radiographics 2014 0.77
89 Anaphylaxis associated with gadolinium-based contrast agents: data from the Food and Drug Administration's Adverse Event Reporting System and review of case reports in the literature. Expert Opin Drug Saf 2013 0.77
90 MR signal intensity calculations are not reliable for differentiating renal cell carcinoma from lipid poor angiomyolipoma. Radiology 2010 0.76
91 MR imaging of acute bowel pathology: a pictorial review. Emerg Radiol 2007 0.76
92 Iron deposition surrounding the hepatic veins of cirrhotic patients on MRI. J Magn Reson Imaging 2011 0.76
93 Correlation between findings on MRCP and gadolinium-enhanced MR of the liver and a survival model for primary sclerosing cholangitis. Dig Dis Sci 2007 0.75
94 Magnetic resonance imaging of the pancreas: the future is now. Semin Ultrasound CT MR 2005 0.75
95 Endometriosis presenting as a urethral diverticulum: a case report. J Reprod Med 2004 0.75
96 MRI findings of posttraumatic intrahepatic vascular shunts. J Magn Reson Imaging 2009 0.75
97 Taking advantage of chemical shift imaging: using opposed-phase images to locate the normal appendix on MR. Clin Imaging 2011 0.75
98 Gastrointestinal and genitourinary smooth-muscle tumors. AJR Am J Roentgenol 2003 0.75
99 Adrenal lesions with heterogeneous suppression on chemical shift imaging: clinical implications. J Magn Reson Imaging 2004 0.75
100 Radiation-induced fibrosis of the spermatic cord: sonographic and MRI findings. AJR Am J Roentgenol 2005 0.75
101 MDCT appearance of the appendix: how does the low-density barium sulfate oral contrast agent affect it? Emerg Radiol 2010 0.75
102 Change in the growth rate of localized pancreatic adenocarcinoma in response to gemcitabine, bevacizumab, and radiation therapy on MDCT. Int J Radiat Oncol Biol Phys 2011 0.75
103 Erratum to: Fluoroscopic findings post-peroral esophageal myotomy. Abdom Imaging 2015 0.75